This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Analysts Estimate Illumina (ILMN) to Report a Decline in Earnings: What to Look Out for
by Zacks Equity Research
Illumina (ILMN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
EXEL or ILMN: Which Is the Better Value Stock Right Now?
by Zacks Equity Research
EXEL vs. ILMN: Which Stock Is the Better Value Option?
Illumina (ILMN) Stock Sinks As Market Gains: What You Should Know
by Zacks Equity Research
Illumina (ILMN) closed the most recent trading day at $302.29, moving -0.9% from the previous trading session.
Company News for Jul 15, 2019
by Zacks Equity Research
Companies In The News Are: ILMN,MCRN,HI,JNJ,ACN
Illumina (ILMN) Grows on Innovation & International Growth
by Zacks Equity Research
Illumina (ILMN) is benefiting from sturdy demand for sequencing and array systems as well as consumables and services.
Illumina (ILMN) Outpaces Stock Market Gains: What You Should Know
by Zacks Equity Research
Illumina (ILMN) closed at $377.24 in the latest trading session, marking a +0.57% move from the prior day.
Illumina (ILMN) Hits 52-Week High, Can the Run Continue?
by Zacks Equity Research
Illumina (ILMN) gains from expansion of its product portfolio and strategic partnership.
Illumina (ILMN) Outpaces Stock Market Gains: What You Should Know
by Zacks Equity Research
Illumina (ILMN) closed the most recent trading day at $377.82, moving +1.74% from the previous trading session.
Five Runaway Breakout Stocks to Buy
by David Bartosiak
With the market at all-time highs again, the rich get richer as stocks continue to breakout.
Illumina (ILMN) Gains As Market Dips: What You Should Know
by Zacks Equity Research
Illumina (ILMN) closed at $358.08 in the latest trading session, marking a +0.1% move from the prior day.
Why These Innovative Biotech ETFs Are Soaring
by Neena Mishra
Strong M&A activity has sent shares of many small, innovative biotech companies surging
The Zacks Analyst Blog Highlights: Invitae, Illumina, Pacific Biosciences and Guardant Health
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Invitae, Illumina, Pacific Biosciences and Guardant Health
The Zacks Analyst Blog Highlights: Middlesex Water, Atlantic Power, NexPoint Residential Trust, Illumina and BioDelivery Sciences International
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Middlesex Water, Atlantic Power, NexPoint Residential Trust, Illumina and BioDelivery Sciences International
5 Top Rate-Sensitive Stocks to Buy Amid Fed's Rate Cut Hints
by Nalak Das
The Fed has said that adoption of more accommodative policy is gaining ground as some economic developments raised concerns about U.S. and global growth.
46 and You: Genetic Testing = Giant Growth Market
by Kevin Cook
Advances in genomic diagnostic technology have made testing affordable for the 99.0% of the world still in line.
Illumina (ILMN) Stock Sinks As Market Gains: What You Should Know
by Zacks Equity Research
Illumina (ILMN) closed the most recent trading day at $347.53, moving -1.02% from the previous trading session.
Moving Average Crossover Alert: Illumina
by Zacks Equity Research
Illumina, Inc. (ILMN) is looking like an interesting pick from a technical perspective, as the company is seeing favorable trends on the moving average crossover front.
GILD vs. ILMN: Which Stock Is the Better Value Option?
by Zacks Equity Research
GILD vs. ILMN: Which Stock Is the Better Value Option?
Medidata (MDSO) to be Acquired by Dassault for $5.8 Billion
by Zacks Equity Research
Dassault's acquisition of Medidata (MDSO) to close by 2019-end.
Illumina (ILMN) Gains As Market Dips: What You Should Know
by Zacks Equity Research
Illumina (ILMN) closed the most recent trading day at $339.15, moving +0.97% from the previous trading session.
The Zacks Analyst Blog Highlights: American International, Arconic, Hasbro, Illumina and Jefferies
by Zacks Equity Research
The Zacks Analyst Blog Highlights: American International, Arconic, Hasbro, Illumina and Jefferies
5 Top S&P 500 Stocks to Fly High Despite Market Volatility
by Nalak Das
The S&P 500 Index recovered the lost ground to a large extent with a gain of 4.4% in the first week of June.
Illumina (ILMN) Gains But Lags Market: What You Should Know
by Zacks Equity Research
Illumina (ILMN) closed the most recent trading day at $318.56, moving +0.13% from the previous trading session.
The Zacks Analyst Blog Highlights: Vertex Pharmaceuticals, Gilead Sciences, Repligen, Illumina and Bio-Techne
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Vertex Pharmaceuticals, Gilead Sciences, Repligen, Illumina and Bio-Techne
5 Biotech Stocks to Buy Right Now
by Zachary Stutler
here are a few stocks that have outperformed their peers and are expected to have continued growth throughout the next couple of years. All the stocks in this list are a Zacks Rank #2 (Buy) or better.